@chaseveryday's tirzepatide claims, fact-checked

What did @chaseveryday actually say?

In a reply video with over a million views, @chaseveryday offered three pieces of advice for people just starting a GLP-1 medication. First, she said injection day timing matters because "three to four days after the injection day" is when you'll have "the most potency of the medicine." Second, she pushed for stocking protein and fiber in advance so you're not relying on cravings to drive food choices. Third, she recommended adding electrolytes in the morning to "prevent nausea" and "prevent headaches" and fatigue, with a reasonable note to check with your doctor first if you have blood pressure concerns. The whole thing is framed as personal experience, not medical advice, and that framing matters when evaluating the claims.

Does the science back this up?

Two of the three claims have real pharmacological and nutritional grounding. One is shakier. The timing claim is the most interesting to pull apart because it sounds precise but the actual pharmacokinetics of tirzepatide and semaglutide are more complicated than a simple "peak potency" window. Tirzepatide reaches peak plasma concentration (Tmax) roughly 8 to 72 hours after subcutaneous injection, with a half-life of approximately 5 days, meaning effects taper gradually rather than spiking and crashing on a predictable schedule. Frias et al. (2021, New England Journal of Medicine) and the SURPASS trial series documented tirzepatide's pharmacokinetics across dose ranges. The protein and fiber advice aligns with evidence on satiety and muscle preservation during caloric restriction. The electrolyte recommendation has indirect support but limited direct GLP-1 trial data.

What did they get wrong (or right)?

The timing claim is partially right and partially oversimplified. It is reasonable to think about your schedule when choosing an injection day, but framing a specific 3-4 day window as peak potency is not how tirzepatide or semaglutide pharmacokinetics actually work. Both drugs have long half-lives by design, which creates relatively stable plasma levels during steady-state dosing, not a sharp mid-week spike. The practical advice underneath the claim, which is to pick an injection day that front-loads support before your most demanding days, is sensible lifestyle planning even if the mechanism she described is imprecise.

The protein and fiber advice is genuinely good. Research on GLP-1 receptor agonists consistently shows that reduced appetite can lead to inadequate protein intake, which accelerates lean mass loss. Wilding et al. (2021, New England Journal of Medicine, STEP 1 trial) noted body composition concerns. Pre-planning meals around lean protein is a real mitigation strategy, not just a wellness platitude.

The electrolyte tip is reasonable harm reduction but the causal chain she implies, that electrolytes specifically prevent GLP-1 nausea, is not well-established. Nausea from GLP-1 medications is primarily driven by gastric motility changes and central GLP-1 receptor activation, not electrolyte depletion. Electrolytes may help with hydration-related fatigue and headaches, which are secondary effects. That is a meaningful difference.

What should you actually know?

Injection day planning is worth thinking about, but do not count on a precise 3-4 day potency window to schedule your week. Your prescribing provider can give you actual pharmacokinetic context for your specific medication and dose. The more reliable version of this advice is simply: pick a day that gives you stable access to food, rest, and hydration in the first 48 hours post-injection, especially in your first weeks.

Protein intake is genuinely one of the most under-discussed risks in GLP-1 weight loss, particularly for people who are also restricting calories aggressively. Aiming for 1.2 to 1.6 grams of protein per kilogram of body weight, a range supported by Phillips and Van Loon (2011, Journal of Sports Sciences), is a reasonable target to discuss with your care team.

On electrolytes: if you are experiencing nausea, vomiting, or significantly reduced fluid intake on GLP-1 therapy, hydration and electrolyte balance are legitimate clinical concerns. But treating electrolyte drinks as a nausea prevention protocol is not the same as managing GLP-1 side effects with evidence-based dose titration, anti-nausea strategies, or dietary adjustments under provider guidance. Talk to your prescriber before adding daily electrolyte supplements, especially if you have kidney disease or cardiovascular conditions, not just hypertension.

Bottom line on this video

@chaseveryday is sharing lived experience, and most of what she says is more useful than average TikTok health advice. The protein and fiber preparation tip is genuinely well-supported. The electrolyte tip is reasonable with caveats. The timing claim is the one that could send people chasing a pharmacological pattern that does not quite match how these drugs work. Credit where it is due, she told viewers to talk to their doctor repeatedly. That is more than most creators do in this space.